Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors
Author:
Funder
National Institutes of Health
Publisher
Frontiers Media SA
Subject
Psychiatry and Mental health
Reference64 articles.
1. New treatments for cocaine dependence: a focused review;Karila;Int J Neuropsychopharmacol,2008
2. Agonist-antagonist combinations in opioid dependence: a translational approach;Mannelli;Dipend Patologiche,2010
3. The Nociceptin/Orphanin FQ receptor (NOP) as a target for drug abuse medications;Zaveri;Curr Top Med Chem,2011
4. The use of bifunctional NOP/Mu and NOP receptor selective compounds for the treatment of pain, drug abuse, and psychiatric disorders;Toll;Curr Pharm Des,2013
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy;Neuropharmacology;2024-10
2. Novel Opioids in the Setting of Acute Postoperative Pain: A Narrative Review;Pharmaceuticals;2023-12-25
3. Cebranopadol for the Treatment of Chronic Pain;Current Pain and Headache Reports;2023-08-09
4. Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy;2023-07-25
5. Nociceptin Receptor-Related Agonists as Safe and Non-addictive Analgesics;Drugs;2023-05-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3